Full Fed Circ. Won't Review Boston Sci Win In $200M IP Suit
The Federal Circuit on Thursday summarily denied en banc review of a cardiologist's $200 million contract lawsuit seeking royalties from Boston Scientific on his stent patents, rejecting the doctor's claim that...To view the full article, register now.
Already a subscriber? Click here to view full article